Christopher M. Lauderback

3.2k total citations · 2 hit papers
14 papers, 2.7k citations indexed

About

Christopher M. Lauderback is a scholar working on Physiology, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Christopher M. Lauderback has authored 14 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Physiology, 6 papers in Molecular Biology and 6 papers in Cellular and Molecular Neuroscience. Recurrent topics in Christopher M. Lauderback's work include Alzheimer's disease research and treatments (9 papers), Neuroscience and Neuropharmacology Research (5 papers) and Electron Spin Resonance Studies (3 papers). Christopher M. Lauderback is often cited by papers focused on Alzheimer's disease research and treatments (9 papers), Neuroscience and Neuropharmacology Research (5 papers) and Electron Spin Resonance Studies (3 papers). Christopher M. Lauderback collaborates with scholars based in United States and Bulgaria. Christopher M. Lauderback's co-authors include D. Allan Butterfield, D. Allan Butterfield, Alessandra Castegna, James Drake, Jarosław Kański, Janna M. Hackett, S. Varadarajan, William R. Markesbery, Jeffrey N. Keller and Luke I. Szweda and has published in prestigious journals such as Journal of the American Chemical Society, Biochemistry and Brain Research.

In The Last Decade

Christopher M. Lauderback

14 papers receiving 2.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Lipid peroxidation and protein oxidation in Alzheimer’s disease brain: potential causes and consequences involving amyloid β-peptide-associated free radical oxidative stress

2002 857 citations D. Allan Butterfield, Christopher M. Lauderback Free Radical Biology and Medicine profile →
Evidence that amyloid beta-peptide-induced lipid peroxidation and its sequelae in Alzheimer’s disease brain contribute to neuronal death1

2002 581 citations Alessandra Castegna, Christopher M. Lauderback et al. Neurobiology of Aging profile →

Peers

Countries citing papers authored by Christopher M. Lauderback

Since Specialization

Citations

This map shows the geographic impact of Christopher M. Lauderback's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher M. Lauderback with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher M. Lauderback more than expected).

Fields of papers citing papers by Christopher M. Lauderback

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher M. Lauderback. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher M. Lauderback. The network helps show where Christopher M. Lauderback may publish in the future.

Co-authorship network of co-authors of Christopher M. Lauderback

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher M. Lauderback. A scholar is included among the top collaborators of Christopher M. Lauderback based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher M. Lauderback. Christopher M. Lauderback is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

#	Work	Indexed citations
1	Modulation of phospholipid asymmetry in synaptosomal membranes by the lipid peroxidation products, 4-hydroxynonenal and acrolein: implications for Alzheimer's disease 2004 ·Brain Research ·Alessandra Castegna, Christopher M. Lauderback, Hafiz Mohmmad‐Abdul, D. Allan Butterfield	81
2	Derivatives of Xanthic Acid are Novel Antioxidants: Application to Synaptosomes 2003 ·Free Radical Research ·Christopher M. Lauderback, Jennifer Drake, Daohong Zhou, Janna M. Hackett, Alessandra Castegna, Jarosław Kański, (unknown), S. Varadarajan, D. Allan Butterfield	29
3	Apolipoprotein E modulates Alzheimer’s Aβ(1–42)-induced oxidative damage to synaptosomes in an allele-specific manner 2002 ·Brain Research ·Christopher M. Lauderback, Jarosław Kański, Janna M. Hackett, (unknown), Mark S. Kindy, D. Allan Butterfield	107
4	Lipid peroxidation and protein oxidation in Alzheimer’s disease brain: potential causes and consequences involving amyloid β-peptide-associated free radical oxidative stress breakdown → 2002 ·Free Radical Biology and Medicine ·D. Allan Butterfield, Christopher M. Lauderback	857
5	Evidence that amyloid beta-peptide-induced lipid peroxidation and its sequelae in Alzheimer’s disease brain contribute to neuronal death1 breakdown → 2002 ·Neurobiology of Aging ·(unknown), Alessandra Castegna, Christopher M. Lauderback, James Drake	581
6	The glial glutamate transporter, GLT‐1, is oxidatively modified by 4‐hydroxy‐2‐nonenal in the Alzheimer's disease brain: the role of Aβ1–42 2001 ·Journal of Neurochemistry ·Christopher M. Lauderback, Janna M. Hackett, Feng Huang, Jeffrey N. Keller, Luke I. Szweda, William R. Markesbery, D. Allan Butterfield	386
7	Glutathione elevation and its protective role in acrolein-induced protein damage in synaptosomal membranes: relevance to brain lipid peroxidation in neurodegenerative disease 2001 ·Neurochemistry International ·Chava B. Pocernich, (unknown), (unknown), Christopher M. Lauderback, D. Allan Butterfield	159
8	5-Aminosalicylic Acid Protection against Oxidative Damage to Synaptosomal Membranes by Alkoxyl Radicals In Vitro 2001 ·Neurochemical Research ·Jarosław Kański, Christopher M. Lauderback, D. Allan Butterfield	16
9	D609 Inhibits Ionizing Radiation-Induced Oxidative Damage by Acting as a Potent Antioxidant 2001 ·Journal of Pharmacology and Experimental Therapeutics ·Daohong Zhou, Christopher M. Lauderback, Tao Yu, Stephen Brown, D. Allan Butterfield, John Thompson	45
10	Different Mechanisms of Oxidative Stress and Neurotoxicity for Alzheimer‘s Aβ(1−42) and Aβ(25−35) 2001 ·Journal of the American Chemical Society ·S. Varadarajan, Jarosław Kański, Marina Aksenova, Christopher M. Lauderback, D. Allan Butterfield	297
11	Vulnerability of Synaptosomes from ApoE Knock-Out Mice to Structural and Oxidative Modifications Induced by Aβ(1−40): Implications for Alzheimer's Disease 2001 ·Biochemistry ·Christopher M. Lauderback, Janna M. Hackett, Jeffrey N. Keller, S. Varadarajan, Luke I. Szweda, Mark S. Kindy, William R. Markesbery, D. Allan Butterfield	56
12	Amyloid β‐Peptide Effects on Synaptosomes from Apolipoprotein E‐Deficient Mice 2000 ·Journal of Neurochemistry ·Jeffrey N. Keller, Christopher M. Lauderback, D. Allan Butterfield, Mark S. Kindy, Jin Yu, William R. Markesbery	52
13	The pyrrolopyrimidine U101033E is a potent free radical scavenger and prevents Fe(II)-induced lipid peroxidation in synaptosomal membranes 2000 ·Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease ·Christopher M. Lauderback, Adam M. Breier, Janna M. Hackett, S. Varadarajan, (unknown), D. Allan Butterfield	11
14	Amyloid β-peptide inhibits Na+-dependent glutamate uptake 1999 ·Life Sciences ·Christopher M. Lauderback, Marni E. Harris‐White, Yaning Wang, Norman W. Pedigo, John M. Carney, D. Allan Butterfield	35

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact